tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Citius Oncology expects commercial launch of Lymphir in second half of 2025
PremiumThe FlyCitius Oncology expects commercial launch of Lymphir in second half of 2025
3M ago
Citius Pharmaceuticals Closes $6M Securities Offering
Premium
Company Announcements
Citius Pharmaceuticals Closes $6M Securities Offering
3M ago
Citius Pharmaceuticals price target lowered to $6 from $9 at D. Boral Capital
Premium
The Fly
Citius Pharmaceuticals price target lowered to $6 from $9 at D. Boral Capital
3M ago
Citius Pharmaceuticals downgraded to Hold from Buy at Maxim
PremiumThe FlyCitius Pharmaceuticals downgraded to Hold from Buy at Maxim
4M ago
Citius Pharmaceuticals Reports Q1 2025 Earnings and Strategic Developments
Premium
Company Announcements
Citius Pharmaceuticals Reports Q1 2025 Earnings and Strategic Developments
4M ago
Citius Pharmaceuticals reports Q2 EPS (11c) vs. (7c) last year
Premium
The Fly
Citius Pharmaceuticals reports Q2 EPS (11c) vs. (7c) last year
4M ago
Citius Pharmaceuticals announces $2M registered direct offering of common stock
PremiumThe FlyCitius Pharmaceuticals announces $2M registered direct offering of common stock
6M ago
Citius Pharma Advances LYMPHIR Launch Amid Financial Updates
Premium
Company Announcements
Citius Pharma Advances LYMPHIR Launch Amid Financial Updates
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100